Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (131-140 of 308) with videos related to

Pageof 31
Sort By:
Nature Genetics|December 4, 2001
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaScott A Armstrong, Jane E Staunton, Lewis B Silverman, et al.
Science Translational Medicine|May 16, 2014
Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemiaTatiana Perova, Ildiko Grandal, Lauryl M J Nutter, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2012
A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignanciesAaron D Schimmer, Yulia Jitkova, Marcela Gronda, et al.
Nature Communications|July 5, 2022
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factorsLina Liu, Ana Vujovic, Nandan P Deshpande, et al.
Leukemia & Lymphoma|September 20, 2016
Chest CT scans are frequently abnormal in asymptomatic patients with newly diagnosed acute myeloid leukemiaJanaki Vallipuram, Sidika Dhalla, Chaim M Bell, et al.
Blood|September 26, 2018
Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasmsJames A Kennedy, Jessie J F Medeiros, Stephanie M Dobson, et al.
Nature Chemical Biology|April 14, 2015
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin BMalia B Potts, Elizabeth A McMillan, Tracy I Rosales, et al.
Nature Communications|May 11, 2017
HLA-DP<sup>84Gly</sup> constitutively presents endogenous peptides generated by the class I antigen processing pathwayYuki Yamashita, Mark Anczurowski, Munehide Nakatsugawa, et al.
Haematologica|September 3, 2016
Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cellsLianne E Rotin, Neil MacLean, Ahmed Aman, et al.
Pageof 31

Showing results (131-140 of 308) with videos related to

Sort By:
Pageof 31
Nature Genetics|December 4, 2001
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaScott A Armstrong, Jane E Staunton, Lewis B Silverman, et al.
Science Translational Medicine|May 16, 2014
Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemiaTatiana Perova, Ildiko Grandal, Lauryl M J Nutter, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2012
A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignanciesAaron D Schimmer, Yulia Jitkova, Marcela Gronda, et al.
Nature Communications|July 5, 2022
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factorsLina Liu, Ana Vujovic, Nandan P Deshpande, et al.
Leukemia & Lymphoma|September 20, 2016
Chest CT scans are frequently abnormal in asymptomatic patients with newly diagnosed acute myeloid leukemiaJanaki Vallipuram, Sidika Dhalla, Chaim M Bell, et al.
Blood|September 26, 2018
Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasmsJames A Kennedy, Jessie J F Medeiros, Stephanie M Dobson, et al.
Nature Chemical Biology|April 14, 2015
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin BMalia B Potts, Elizabeth A McMillan, Tracy I Rosales, et al.
Nature Communications|May 11, 2017
HLA-DP<sup>84Gly</sup> constitutively presents endogenous peptides generated by the class I antigen processing pathwayYuki Yamashita, Mark Anczurowski, Munehide Nakatsugawa, et al.
Haematologica|September 3, 2016
Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cellsLianne E Rotin, Neil MacLean, Ahmed Aman, et al.
Pageof 31